Company profile: Conformal Medical
1.1 - Company Overview
Company description
- Provider of transcatheter left atrial appendage occlusion solutions to prevent stroke in patients with nonvalvular atrial fibrillation, including the Conformal Left Atrial Appendage System (CLAAS) implant and the CONFORM clinical trial evaluating CLAAS versus other commercially available LAAO devices.
Products and services
- Conformal Left Atrial Appendage System (CLAAS): A transcatheter implant that occludes the left atrial appendage to prevent stroke in patients with nonvalvular atrial fibrillation
- CONFORM Clinical Trial: A comparative clinical study evaluating the CLAAS System against other commercially available LAAO devices in patients with non-valvular atrial fibrillation
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Conformal Medical
Embera NeuroTherapeutics
HQ: United States
Website
- Description: Provider of development-stage pharmaceutical therapies for smoking cessation and other addictions with limited or no approved treatments. Developing EMB-001, a patented combination of metyrapone and oxazepam targeting complementary brain pathways and moderating activity in the stress response system. Completed Phase 1 studies in smokers; Phase 2 ongoing in cocaine use disorder and smoking cessation.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Embera NeuroTherapeutics company profile →
ADRx
HQ: United States
Website
- Description: Provider of a structure-based drug discovery platform that transforms atomic structures into small molecule therapies for protein aggregation diseases, targeting pathological protein structures. Develops small molecule modulators of protein-protein interactions, including amyloids and biomolecular condensates, and advances drug candidates for Alzheimer’s, systemic amyloidosis, ovarian cancer, ALS, and Parkinson’s.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full ADRx company profile →
Lobe Sciences
HQ: Canada
Website
- Description: Provider of life sciences focused on transformational medicine.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Lobe Sciences company profile →
Sonoma Bio
HQ: United States
Website
- Description: Provider of Treg and Teff cell therapies and autoimmune disease research, developing adoptive Treg therapies for rheumatoid arthritis, inflammatory bowel disease, and hidradenitis suppurativa. Pipeline includes SBT-77-7101, a Treg cell therapy targeting citrullinated proteins to reduce inflammation, and SBT-11-5301, a Phase 1 effector T cell-modulating biologic, with clinical trials assessing safety and effectiveness.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Sonoma Bio company profile →
Baergic Bio
HQ: United States
Website
- Description: Provider of novel therapeutics for the treatment of central nervous system (CNS) disorders, developed and commercialised by a biopharmaceutical company.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Baergic Bio company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Conformal Medical
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Conformal Medical
2.2 - Growth funds investing in similar companies to Conformal Medical
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Conformal Medical
4.2 - Public trading comparable groups for Conformal Medical
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →